Nippon India Nifty Pharma ETF

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Category : Index Funds/ETFs

Fund House : Nippon India Mutual Fund

NAV

This number shows latest NAV (Net Asset Value) and change in the NAV from previous day. NAV is nothing but the unit price for the fund. You will be allocated number of units based on this price. NAV is declared once each day generally at the end of the day. Once you invest in mutual funds, your money is further invested in stocks and bonds by mutual fund managers. Mutual Fund NAV is the per unit latest value of all such stocks/bonds held in the portfolio

: ₹ 23.147 1%
(as on 12th November, 2025)

Crisil Rating

Not Rated

Rank not available for the fund

Fund Size

: ₹ 1022.91 Cr

(0.08% of Investment in Category)

Expense Ratio

: 0.21%

(0.52% Category average)

Risk-O-Meter

Very High Risk

Index Funds/ETFs :Index Funds/ETFs : The fund has 99.97% investment in domestic equities of which 53.22% is in Large Cap stocks, 19.74% is in Mid Cap stocks, 2.61% in Small Cap stocks.

1M
3M
6M
1Y
2Y
5Y
ALL

This Scheme

VS

Nifty Pharma TRI

1.71%

3.91%

7.59%

2.73%

21.31%

15.11%

11.49%
NA
1.72%

6.31%

8.29%

10.64%

17.23%

18.48%

12.18%

NA
Gold

Compare with

Date : -
NAV : -

1M
3M
6M
9M
1Y
2Y
3Y
5Y
ALL

Date : -
Investment : -
Value on selected date : -

Returns Calculator
SIP Calculator
VIP (Value Avg)

Amount

₹

Investment Date
Sell Date

Investment Value

-
Sell Value

-
Profit/Loss

-
Annualised Returns

-

Date : -
Investment : -
Value on selected date : -

Returns (NAV as on 12th November, 2025)

Period Invested for	₹10000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	04-Nov-25	10116.90	1.17%	-	0.93%	215/726
1 Month	10-Oct-25	10168.70	1.69%	-	1.72%	390/721
3 Month	12-Aug-25	10384.50	3.85%	-	6.31%	463/702
6 Month	12-May-25	10746.40	7.46%	-	8.29%	217/662
YTD	01-Jan-25	9681.60	-3.18%	-	10.01%	535/605
1 Year	12-Nov-24	10250.70	2.51%	2.51%	10.64%	473/579
2 Year	10-Nov-23	14688.90	46.89%	21.10%	17.23%	109/452
3 Year	11-Nov-22	17620.90	76.21%	20.74%	16.65%	94/345
Since Inception	06-Jul-21	16063.40	60.63%	11.49%	12.18%	336/758

Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 12th November, 2025)

Period Invested for	₹1000 SIP Started on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	12-Nov-24	12000	12531.17	4.43 %	8.27 %
2 Year	10-Nov-23	24000	26781.78	11.59 %	10.9 %
3 Year	11-Nov-22	36000	47539.82	32.06 %	18.87 %

SIP Calculator Detailed Returns Analysis

Tax Treatment

Please check with your Tax Advisor.

Portfolio (Updated on 31st Oct,2025)

Equity Holding : 99.97% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.97%

No of Stocks : 20 (Category Avg - 54.43) | Large Cap Investments : 53.22%| Mid Cap Investments : 19.74% | Small Cap Investments : 2.61% | Other : 24.4%

Top 10 Stocks in Portfolio

How to read this table?

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
# Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	2268.9	22.18%	0.00%	25.53% (Apr 2025)	21.62% (Sep 2025)	13.42 L	-1.12 k
# Divis Laboratories Ltd.	Pharmaceuticals	1089.9	10.65%	0.00%	11.02% (May 2025)	9.3% (Sep 2025)	1.62 L	-0.14 k
# Cipla Ltd.	Pharmaceuticals	1075.3	10.51%	0.00%	11.43% (Aug 2025)	10.21% (Dec 2024)	7.16 L	-0.60 k
# Dr. Reddys Laboratories Ltd.	Pharmaceuticals	929.1	9.08%	0.00%	10.29% (Dec 2024)	9.29% (Mar 2025)	7.76 L	-0.65 k
# Lupin Ltd.	Pharmaceuticals	604.9	5.91%	0.00%	6.9% (Dec 2024)	5.7% (Jul 2025)	3.08 L	-0.26 k
# Torrent Pharmaceuticals Ltd.	Pharmaceuticals	474.2	4.64%	0.00%	4.85% (Sep 2025)	3.71% (Oct 2024)	1.33 L	-0.11 k
# Laurus Labs Ltd.	Pharmaceuticals	471.8	4.61%	0.00%	4.29% (Aug 2025)	2.43% (Oct 2024)	4.95 L	-0.41 k
# Aurobindo Pharma Ltd.	Pharmaceuticals	405.6	3.97%	0.00%	4.9% (Oct 2024)	3.68% (Aug 2025)	3.56 L	-0.30 k
# Alkem Laboratories Ltd.	Pharmaceuticals	394.8	3.86%	0.00%	3.93% (Sep 2025)	3.31% (Jul 2025)	71.71 k	-60.00
# Glenmark Pharmaceuticals Ltd.	Pharmaceuticals	362.7	3.55%	0.00%	3.93% (Jul 2025)	2.69% (Apr 2025)	1.92 L	-0.17 k

- indicates change in weight in the portfolio. # indicates a new entry.

Detailed Portfolio Analysis

Name	Type of Instrument	Weight (%)
TREPS	TREPS	0.38%
Margin	Margin	0.00%
Net Receivables	Net Receivables	-0.35%

Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)

Standard Deviation
Standard Deviation value gives an idea about how volatile fund returns has been in the past 3 years. Lower value indicates more predictable performance. So if you are comparing 2 funds (lets say Fund A and Fund B) in the same category. If Fund A and Fund B has given 9% returns in last 3 years, but Fund A standard deviation value is lower than Fund B. So you can say that there is a higher chance that Fund A will continue giving similar returns in future also whereas Fund B returns may vary.

High volatility

14.42vs10.99

Category Avg
Beta
Beta value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market. So if you are comparing 2 funds (lets say Fund A and Fund B) in the same category. If Fund A and Fund B has given 9% returns in last 3 years, but Fund A beta value is lower than Fund B. So you can say that there is a higher chance that Fund A will continue giving similar returns in future also whereas Fund B returns may vary.

High volatility

1vs0.85

Category Avg
Sharpe Ratio
Sharpe ratio indicates how much risk was taken to generate the returns. Higher the value means, fund has been able to give better returns for the amount of risk taken. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns. For example, if fund A and fund B both have 3-year returns of 15%, and fund A has a Sharpe ratio of 1.40 and fund B has a Sharpe ratio of 1.25, you can chooses fund A, as it has given higher risk-adjusted return.

Poor risk adjusted returns

0.91vs1

Category Avg
Treynor's Ratio
Treynor's ratio indicates how much excess return was generated for each unit of risk taken. Higher the value means, fund has been able to give better returns for the amount of risk taken. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the beta of returns. For example, if fund A and fund B both have 3-year returns of 15%, and fund A has a Treynor's ratio of 1.40 and fund B has a Treynor's ratio of 1.25, then you can chooses fund A, as it has given higher risk-adjusted return.

Poor risk adjusted returns

0.13vs0.61

Category Avg
Jensen's Alpha
Alpha indicates how fund generated additional returns compared to a benchmark. Let's say if a fund A benchmarks its returns with Nifty50 returns then alpha equal to 1.0 indicates the fund has beaten the nifty returns by 1%, so the higher the alpha, the better.

Poor risk adjusted returns

-0.22vs1.27

Category Avg

Alternative Funds (Category Peers)

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Tata Silver Exchange Traded Fund	NA	1189.44	5.85	38.14	65.23	74.96	0.00
ICICI Prudential Silver ETF	NA	9445.03	-3.68	37.24	61.73	74.74	34.18
Aditya Birla Sun Life Silver ETF	NA	1756.21	-3.69	37.15	64.69	74.70	34.22
DSP Silver ETF	NA	1374.63	-3.59	37.26	64.75	74.66	34.45
Mirae Asset Silver ETF	NA	460.88	-3.65	37.16	64.62	74.54	0.00
Axis Silver ETF	NA	720.88	-3.67	37.07	64.56	74.54	34.05
Kotak Silver ETF	NA	2305.14	-3.70	37.13	64.56	74.46	0.00
SBI Silver ETF	NA	2330.68	-3.67	37.07	61.39	74.28	0.00
HDFC Silver ETF	NA	3177.76	-3.64	37.17	64.60	74.26	34.03
Nippon India Silver ETF	NA	17525.28	-3.70	37.08	64.45	74.15	34.30

Detailed Comparison

More Funds from Nippon India Mutual Fund

Out of 130 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 10 is/are ranked 4 * , 15 is/are ranked 3 * , 6 is/are ranked 2 * , 3 is/are ranked 1 * , and 95 schemes are not ranked. See more about AMC

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Small Cap Fund - Growth	4	68969.15	0.89	2.86	8.17	-0.82	22.68
Nippon India ETF Nifty 50 BeES	4	53989.02	2.48	5.88	4.81	9.67	13.36
Nippon India ETF Nifty 50 BeES	4	53989.02	2.48	5.88	4.81	9.67	13.36
Nippon India Multicap Fund - Growth	4	49313.70	0.50	3.02	7.80	5.38	21.83
Nippon India Large Cap Fund - Growth	5	48870.60	1.33	4.72	6.46	8.82	18.65
Nippon India Growth Mid Cap Fund - Growth	4	41267.69	2.05	5.27	9.77	7.16	25.44
Nippon India ETF Gold BeES	NA	32605.96	1.98	23.55	32.15	62.82	31.55
Nippon India ETF Gold BeES	NA	32605.96	0.00	0.00	0.00	0.00	0.00
CPSE ETF	NA	30725.34	-0.52	3.06	4.22	3.57	34.46
CPSE ETF	NA	30725.34	-0.51	3.09	4.28	3.65	34.75